CompletedNot Applicable

The Oncopanel Pilot (TOP) Study

Canada432 participantsStarted 2014-10

Plain-language summary

The BCCA Oncopanel is a clinical assay being developed to determine genotype status of a prospectively defined set of genes. The purpose of this pilot study is to assess the feasibility and effect on clinical-decision-making of the Oncopanel test. Eligible patients are those with advanced lung, colorectal, melanoma and GIST cancers and patients with diagnosed malignancies being considered for clinical trials.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Patients with archival tumor tissue and a known history of invasive malignancies are eligible if they meet one or more of the following criteria: * Advanced colorectal cancer and eligible for standard KRAS testing, * Advanced non-small cell lung cancer and eligible for standard EGFR testing, * Advanced melanoma and eligible for standard BRAF testing, * Gastrointestinal stromal tumors (GISTs) eligible for standard c-KIT and PDGFRA testing, * Being considered for potential eligibility in clinical trial.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of days between receipt of archival tumour tissue and generation of the OncoPanel Report

Timeframe: 10 business days

Trial details

NCT IDNCT02171286

SponsorBritish Columbia Cancer Agency

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-03

View on ClinicalTrials.gov More Colorectal Cancer Metastatic trials